<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Higher serum <z:chebi fb="0" ids="16990">bilirubin</z:chebi> levels may be implicated cardiovascular protection </plain></SENT>
<SENT sid="1" pm="."><plain>It is unknown whether the impact of serum <z:chebi fb="0" ids="16990">bilirubin</z:chebi> on carotid artery intima media thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>), a marker of subclinical <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, is different in diabetic subjects compared to non-diabetic subjects </plain></SENT>
<SENT sid="2" pm="."><plain>We assessed relationships of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> with serum total <z:chebi fb="0" ids="16990">bilirubin</z:chebi> in non-diabetic and Type 2 diabetic subjects without clinically manifest <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>, total <z:chebi fb="0" ids="16990">bilirubin</z:chebi>, transaminases, C-reactive protein (CRP) and <z:chebi fb="23" ids="18059">lipid</z:chebi> levels were measured in 40 predominantly middle-aged non-diabetic and 80 diabetic subjects </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> was higher in diabetic subjects compared to non-diabetic subjects (unadjusted, p&lt;0.001), whereas <z:chebi fb="0" ids="16990">bilirubin</z:chebi> was not different (p=0.82) </plain></SENT>
<SENT sid="5" pm="."><plain>In both non-diabetic and in diabetic subjects, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> was negatively related to <z:chebi fb="0" ids="16990">bilirubin</z:chebi> (β=-0.316, p=0.045 and β=-0.247 p=0.014, respectively) taking account of age, sex and mean arterial pressure </plain></SENT>
<SENT sid="6" pm="."><plain>In the combined subjects, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> remained independently related to <z:chebi fb="0" ids="16990">bilirubin</z:chebi> (β=-0.183, p=0.028) after additional adjustment for <z:mp ids='MP_0002055'>diabetes</z:mp> status, alcohol intake, transaminases, CRP and <z:chebi fb="23" ids="18059">lipid</z:chebi> levels </plain></SENT>
<SENT sid="7" pm="."><plain>There was no interaction of <z:chebi fb="0" ids="16990">bilirubin</z:chebi> with the presence of <z:mp ids='MP_0002055'>diabetes</z:mp> on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> (p=0.98) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: Carotid artery <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> relates negatively to <z:chebi fb="0" ids="16990">bilirubin</z:chebi> in non-diabetic and Type 2 diabetic subjects </plain></SENT>
<SENT sid="9" pm="."><plain>The association of subclinical <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> with <z:chebi fb="0" ids="16990">bilirubin</z:chebi> appears to be unaltered in the diabetic state </plain></SENT>
</text></document>